However, we found that SCID mice bearing orthotopic SN12C-VHL-KD tumors demonstrated significantly reduced RCC metastasis to specific organs when CXCL12 was depleted by specific neutralizing antibodies, demonstrating the importance of CXCL12 biology in mediating tumor metastasis. This evidence concerns the gene CXCL12 and renal cell carcinoma.